Nxu, Inc. (NXUR): Nasdaq/NYSE listing notice — Nxu receives Nasdaq delisting notice for bid price non-compliance; 180-day cure to Sep 30, 2024

Nxu, Inc.

On April 2, 2024, Nxu received Nasdaq notice for failing to meet $1.00 minimum bid price continued listing requirement.
Company has 180 calendar days, until Sep 30, 2024, to regain compliance by closing at $1.00+ for 10 consecutive days.
If not cured, may seek additional 180-day period if it meets other initial listing requirements and intends reverse stock split.
Board approved $90,000 cash stipends to Directors Ide and Nightengale and $40,000 to Director Billingsley for increased duties.

item 3.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Nxu, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

April 2, 2024, Nxu Inc. (the “Company”) received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company is not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market (the “Bid Price Requirement”). The Notice has no immediate effect on the listing of the Company’s Class A common stock on Nasdaq and, in accordance with Nasdaq Listing Rules, the Company will have 180 calendar days, or until September 30, 2024, to regain compliance with the Bid Price Requirement.

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Nxu, Inc. filing history →

Source: SEC EDGAR

accession 0001214659-24-006244

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.